What is Market Size for WOMEN'S HEALTH DIAGNOSTICS MARKET?
The growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe, increasing adoption of POC diagnostic testing and the growth in the number of diagnostic and imaging centers support the growth of the market.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=128928901
Diagnosis and treatment of problems and diseases that can
harm a woman's physical and mental health is called women's health checkup.
Market Segmentation
Based on application, the women’s health diagnostics
market is segmented into osteoporosis testing, OVC testing, cervical cancer
testing, breast cancer testing, pregnancy & fertility testing, prenatal
genetic screening & carrier testing, infectious disease testing, STD
testing, and ultrasound tests.
Based on end user, the women’s health diagnostics
market is segmented into hospitals & clinics, diagnostic & imaging
centers, and home care settings. The hospitals & clinics segment accounted
for the largest share of the women’s health diagnostics market
Regional Analysis
The Asia Pacific women’s health diagnostics market is
expected to grow at the highest CAGR from 2020 to 2025. Improving healthcare
infrastructures, growing per capita incomes, and the rising focus of key market
companies in this region are major factors driving the growth of the APAC
women’s health diagnostics market.
Key Market Players
The prominent players in this market are Quest Diagnostics
Incorporated (US), Hologic, Inc. (US), Abbott Laboratories (US), Siemens AG
(Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health, Inc. (US),
General Electric Company (US), and Becton, Dickinson and Company (US).
Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION
@ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=128928901
Expected Revenue Growth:
The global women’s health diagnostics market is projected to
reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9%
during the forecast period
Hologic, Inc. holds the leading position in the
women’s health diagnostics market, owing to its robust portfolio of breast
imaging products and related accessories. Hologic has expanded its product
portfolio through insight-driven innovation and strategic M&As to establish
its position in the market.
Comments
Post a Comment